Treating Chronic Dry Eye with TearCare LipiTherapy
A common cause of dry eye is something technically called Meibomian Gland Dysfunction, or MGD. The Meibomian Gland produces vital oil that aids in keeping your eye appropriately moist. When the gland becomes clogged, less oil is produced and can result in chronic dry eye.
TearCare LipiTherapy is a new treatment for relieving dry eye caused by Meibomian Gland Dysfunction or clogged Meibomian glands. TearCare is a thermal, open-eye process for comprehensively treating clogged oil glands of a person with chronic dry eye.
Other treatments for clogged glands require a patient to sit for a more extended period of time with eyes closed. Closed-eye treatments of this nature impair what an eye doctor can do to fully treat a patient. These processes may prevent a doctor from personalizing or customizing treatment to meet the specific needs of a person suffering from chronic dry eye.
Thanks to TearCare LipiTherapy, treatment for the most common cause of dry eye can be closely personalized to optimize results. A patient can blink normally, a process which works to enhance the overall TearCare dry eye treatment process.
TearCare integrates an array of technologies to provide a reliable treatment modality for people with chronic dry eye. The entire treatment system is software-controlled to ensure the specific needs of an individual patient fully are met.
